ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127 | -18.1% | 42,242 | +2.4% | 0.00% | – |
| Q2 2023 | $155 | +15.7% | 41,232 | +3.7% | 0.00% | – |
| Q1 2023 | $134 | -3.6% | 39,744 | +37.9% | 0.00% | – |
| Q4 2022 | $139 | -99.9% | 28,813 | +4.3% | 0.00% | – |
| Q3 2022 | $158,000 | -3.7% | 27,621 | +19.7% | 0.00% | – |
| Q2 2022 | $164,000 | -94.9% | 23,081 | -94.8% | 0.00% | – |
| Q1 2022 | $3,220,000 | -12.8% | 445,960 | +8.0% | 0.00% | – |
| Q4 2021 | $3,691,000 | -93.0% | 412,915 | -72.4% | 0.00% | -100.0% |
| Q3 2021 | $52,449,000 | +44.4% | 1,495,965 | -11.6% | 0.01% | +66.7% |
| Q2 2021 | $36,333,000 | -76.4% | 1,691,482 | -34.0% | 0.00% | -80.0% |
| Q1 2021 | $153,805,000 | +50.4% | 2,561,375 | +1.7% | 0.02% | +50.0% |
| Q4 2020 | $102,251,000 | – | 2,517,977 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |